openPR Logo
Press release

UK Genomic Biomarker Market Segmentation, Forecast, Market Analysis, Industry Size and Share to 2025

01-20-2020 01:57 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Reports

UK Genomic Biomarker Market

UK Genomic Biomarker Market

The UK genomic biomarker market is estimated to grow significantly at a CAGR of more than 15% during the forecast period. The major factors driving market growth include a high prevalence of cancer and chronic diseases in the region. The healthcare expenditure in UK has increased significantly as compared to that of other countries in the European region. This is one of the prime reasons which is expected to increase the investment in R&D of new technologies such as genomic biomarkers for the treatment of chronic diseases. Further, the prevalence of cardiac diseases has been increasing in UK.

To learn more about UK Genomic Biomarker Market report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-genomic-biomarkers-market

UK has the highest number of CVD, CHD, Stroke, heart failure, atrial fibrillation, and other heart patients. The use of genomic biomarker is used to implement the suitable drug therapy to the patients suffering from cardiovascular diseases, thereby providing personalized treatment options to the patient and thereby creating opportunities for the growth of the market in the near future.

The UK genomic biomarker market is segmented on the basis of application and end-user. On the basis of application, the market is segmented into oncology, cardiology, neurology, and others. There is a huge scope for the market in the oncology segment due to the increasing prevalence of cancer. On the basis of end-user, the market is segmented into hospitals and diagnostic.

A full report of UK Genomic Biomarker Market is available at: https://www.omrglobal.com/industry-reports/uk-genomic-biomarkers-market

UK Genomic Biomarker Market-Segmentation

By Application
• Oncology
• Cardiology
• Neurology
• Others

By End-User
• Hospitals
• Diagnostic & Research Laboratories

Company Profiles
• Avacta Group Plc
• Bayer AG
• BioMérieux S.A.
• Bio-Rad Laboratories, Inc.
• DestiNA Genomics Ltd.
• Eagle Genomics Ltd.
• Epistem Ltd
• Eurofins Scientific SE
• F-Hoffman-La Roche Ltd.
• Valirx PLC

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-genomic-biomarkers-market

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release UK Genomic Biomarker Market Segmentation, Forecast, Market Analysis, Industry Size and Share to 2025 here

News-ID: 1901401 • Views:

More Releases from Orion Market Reports

Muscarinic Acetylcholine Receptor M4 Market Analysis, Size, Current Scenario and Future Prospects
Muscarinic Acetylcholine Receptor M4 Market Analysis, Size, Current Scenario and …
The Muscarinic Acetylcholine Receptor M4 Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Muscarinic acetylcholine receptor M4 (M4 receptor) is a type of muscarinic receptor that belongs to the G protein-coupled receptor (GPCR) family. Muscarinic Acetylcholine Receptor M4 Market research report is one of the effective ways to target customers and satisfy their growing needs as it gathers all the
Neuroendocrine Tumor Drug Market Competitive Landscape, Growth Factors, Revenue Analysis by 2031
Neuroendocrine Tumor Drug Market Competitive Landscape, Growth Factors, Revenue …
The Neuroendocrine Tumor Drug Market size is expected to grow at an annual average of CAGR 8% during the forecast period (2024-2031). Neuroendocrine tumors (NETs) are a diverse group of neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. These tumors can occur throughout the body but are most commonly found in the gastrointestinal tract, pancreas, and lungs. Treatment of NETs often involves a combination of surgery,
Metabotropic Glutamate Receptor 7 Market Worldwide Industry Analysis, Future Demand and Forecast till 2031
Metabotropic Glutamate Receptor 7 Market Worldwide Industry Analysis, Future Dem …
The Metabotropic Glutamate Receptor 7 Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The metabotropic glutamate receptor 7 (mGlu7) is a G protein-coupled receptor that plays important roles in synaptic transmission and plasticity in the brain. mGlu7 is expressed presynaptically on excitatory and inhibitory neurons, and its activation inhibits the release of glutamate and GABA, respectively. Previous work has shown
Obsessive-Compulsive Disorder Treatment Market to Witness Robust Expansion by 2031
Obsessive-Compulsive Disorder Treatment Market to Witness Robust Expansion by 20 …
The Obsessive-Compulsive Disorder Treatment Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Obsessive compulsive disorder (OCD) was once thought to be extremely rare, but recent epidemiological studies have shown it to be the fourth most common psychiatric disorder (after substance abuse, specific phobias, and major depression). OCD is often a chronic disorder that produces significant morbidity when not properly diagnosed

All 5 Releases


More Releases for Genomic

Genomic Biomarkers Market 2022 | Detailed Report
The research reports on “Genomic Biomarkers Market” report gives detailed overview of factors that affect global business scope. Genomic Biomarkers Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5334064 The
Global Cancer Genomic Testing Market Demand 2020-2025
GLOBAL INFO RESEARCHadded a new COVID-19 research report to its exhaustive repository. The research report, titled [Global and China Cancer Genomic Testing Market 2020 by Company, Type and Application, Forecast to 2025], presents an unbiased approach at understanding the market trends and dynamics. Analysts have studied the historical data pertaining to the market and compared it to the current market trends to paint an object picture of the market's trajectory.
Latest Survey on Genomic Medicine Market 2019 by Key Companies Overview-BioMed C …
The recently published report called “Global Genomic Medicine Market 2019” offers a brief overview of the Genomic Medicine market across the globe. The research report showcases innovative tool for evaluating the complete scenario of the Genomic Medicine market with its tactical decision making, opportunities and supporting strategic. Furthermore, the report also analyses the competitive analysis as well as changing trends which becomes most crucial in order to monitor the performance
Genomic Medicine Market Share and Growth 2019| BioMed Central, Cleveland Clinic, …
The report on the global Genomic Medicine market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Genomic Medicine Market. It offers a detailed analysis of the competition and leading companies of the global Genomic Medicine
Cardiology Genomic Testing Market Impact Analysis By 2028
Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases. Identification of genetic causes can save lives. The technology used for cardiology
Emerging Growth of Global Genomic Medicine Market to 2019-2025| Center for Genom …
Researchmoz (RMOZ) added Most up-to-date research on "Global Genomic Medicine Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. NHGRI defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care and the health outcomes and policy implications of that clinical use." Backed by government investments in precision medicine initiatives such as a multimillion dollar investment by